Skip to content

McKesson MCK Net Income

Net Income at other companies

Eli Lilly logo
Eli LillyLLY
$7.4B+168%
Cardinal Health logo
Cardinal HealthCAH
$399M-21.1%
Cencora logo
CencoraCOR
$1.64B+129%
AbbVie logo
AbbVieABBV
$695M-46.0%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$62.26M+411%
Viatris logo
ViatrisVTRS
$176.4M+106%

Other financials

Income statement

See full
Revenue$96.3B+6.0%
Gross profit$4.0B+11.1%
Operating income$2.2B+35.1%
EPS (diluted)$13.65+37.6%

Balance sheet

See full
Cash & equivalents$4.0B-33.3%
Total debt$2.3B-74.2%
Total equity-$2.2B-4.7%
Total assets$82.3B+9.6%

Cash flow

See full
Operating cash flow$3.4B-55.8%
CapEx$111.0M-34.3%
Free cash flow$3.3B-56.3%

Valuation

See full
Market cap$89.43B-0.8%
Enterprise value$87.73B-5.7%
P/E18.8×-8.6×
P/S0.2×0.0×

Profitability

See full
Gross margin3.6%-0.1pp
Operating margin1.5%+0.3pp
Net margin1.2%+0.3pp
FCF margin1.4%-0.1pp

Returns & leverage

See full
Return on equity36%
Debt / equity
Current ratio0.9×0.0×

Where this comes from

Reported directly by McKesson in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: McKesson’s 10-K, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about McKesson's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is McKesson's net income?
McKesson (MCK) reported net income of $1.68B in Q1 2026.
How has McKesson's net income changed year-over-year?
McKesson's net income increased by 33.5% year-over-year, from $1.26B to $1.68B.
What is the long-term trend for McKesson's net income?
Over 4 years (2022 to 2026), McKesson's net income has grown at a 43.8% compound annual growth rate (CAGR), from $1.11B to $4.76B.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.